Verrica Pharmaceuticals Inc.
VRCA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $21 | $15 | $30 | $46 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $7 | $17 | $6 | $0 |
| Inventory | $2 | $3 | $2 | $2 |
| Other Curr. Assets | $6 | $1 | $2 | $2 |
| Total Curr. Assets | $36 | $37 | $39 | $51 |
| Property Plant & Equip (Net) | $2 | $2 | $2 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $3 | $0 | $0 | $0 |
| Total NC Assets | $5 | $2 | $3 | $3 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $41 | $39 | $42 | $54 |
| Liabilities | – | – | – | – |
| Payables | $2 | $2 | $1 | $2 |
| Short-Term Debt | $13 | $13 | $13 | $14 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $2 | $0 | $0 | $0 |
| Other Curr. Liab. | $13 | $13 | $14 | $14 |
| Total Curr. Liab. | $29 | $29 | $29 | $29 |
| LT Debt | $23 | $26 | $29 | $32 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $6 | $2 | $2 | $3 |
| Total NC Liab. | $29 | $27 | $31 | $35 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $2 | $2 | $2 |
| Total Liabilities | $58 | $57 | $61 | $64 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$317 | -$317 | -$317 | -$307 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $300 | $299 | $298 | $297 |
| Total Equity | -$17 | -$17 | -$19 | -$10 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $41 | $39 | $42 | $54 |
| Net Debt | $15 | $23 | $13 | -$0 |